Home » Topics » Regulatory » Patents

Patents
RSS

Chengdu Institute of Biology identifies sparstolonin B derivatives

Aug. 30, 2016

Centaurus BioPharma, Jiangsu Chia Tai Tianqing and Lianyungang Ruzhong patent DPP-IV inhibitors

Aug. 30, 2016

University of Athens, University of California patent PLA2 inhibitors

Aug. 30, 2016

Trillium Therapeutics discovers bromodomain-containing protein inhibitors

Aug. 29, 2016

Sorrento Therapeutics discloses anti-HER2 antibody-dolastatin derivative conjugates

Aug. 29, 2016

Ginkgo Pharmaceutical describes novel nucleoside derivatives

Aug. 29, 2016

Sage Therapeutics patents GABA (A) receptor modulators

Aug. 29, 2016

Piramal Enterprises discloses GPR120 agonists

Aug. 29, 2016

Sorrento Therapeutics discloses anti-HER2 antibody-anthracycline conjugates

Aug. 26, 2016

Rugen Holdings reports NR2B receptor antagonists

Aug. 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...